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Aim
Pulmonary embolism (PE) is a known cause of morbidity
and mortality in oncology patients. Whilst much of the
literature focuses on the detection of incidental PE in this
cohort of patients (approximately 4%), little is written
about the rate of positive CT Pulmonary Angiograms
(CTPA) when PE is clinically suspected. We wanted to
assess the rate of positive CTPA specifically amongst
oncology patients with suspected PE in our teaching
hospital.
Methods
We retrospectively analysed all consecutive CTPAs carried
out for clinically suspected PE over a 12 month period in
all patients under our oncology services.
Results
A total of 230 oncology patients had a CTPA to exclude
PE and 40 were positive (17.4%). Of the positive CTPAs,
most (31 scans, 77.5%) showed multiple PEs. The com-
monest cancer patients to undergo CTPA were lung (38),
breast (34) and lymphoma (26) patients, and the highest
incidence of positive CTPA were in breast (7/34), ovarian
(2/9) and pancreatic (2/5) carcinoma. CTPAs carried out
in colorectal carcinoma patients had the lowest probability
of being positive (1/15).
Conclusion
The published rate of positive CTPA for clinically sus-
pected PE in the general population is 15-20%. Our study
shows that despite the widely held view that oncology
patients are more prone to pulmonary thromboembolic
disease, the incidence of positive CTPA is in fact similar
to the general population. Our threshold for imaging
oncology patients should therefore be the same as in the
general population.
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